Latest Articles

Publication Date
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
UPDATE ON MEDICAL TREATMENT OF ENDOMETRIOSIS: NEW DRUGS OR NEW THERAPEUTIC APPROACHES?

No conceptually new drugs for the safe and successful cure of endometriosis are likely to become available soon. Hormonal modulation of ovarian function and suppression of menstruation remain the pillars …

Published: Dec. 26, 2024, midnight
Recent Trends in Medical Management of Endometriosis.

Endometriosis affects about 10 percent women in the reproductive age group globally and approximately 42 million in India. Managing the patient's pain symptoms associated with endometriosis appears to be the …

Published: Dec. 26, 2024, midnight
The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including oral administration, …

Published: Dec. 12, 2024, midnight
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis.

Endometriosis affects over 190 million women globally, and effective therapies are urgently needed to address the burden of endometriosis on women's health. Using an artificial intelligence (AI)-driven target discovery platform, …

Published: Dec. 12, 2024, midnight
NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye - BioWorld Online

NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye BioWorld Online

Published: Dec. 5, 2024, 9:35 p.m.
Long-term use of certain progestogen drugs may raise risk of intracranial meningioma - MSN

Long-term use of certain progestogen drugs may raise risk of intracranial meningioma MSN

Published: Dec. 2, 2024, 9:18 a.m.
Endometriosis Treatment Drugs Market Overall Study Report - openPR

Endometriosis Treatment Drugs Market Overall Study Report openPR

Published: Nov. 13, 2024, 12:22 p.m.
Migraine molecules may drive endometriosis pain. Existing drugs might help. - Livescience.com

Migraine molecules may drive endometriosis pain. Existing drugs might help. Livescience.com

Published: Nov. 6, 2024, 7:01 p.m.
[Exploring non-hormonal therapies and drug repositioning for endometriosis: insights from mouse model studies].

The mainstay of treatment for endometriosis is hormonal therapy, which suppresses ovulation; therefore, patients cannot conceive during treatment. There is a dilemma with ovarian-sparing surgery, known as laparoscopic cystectomy, as …

Published: Nov. 6, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!